Back
 IJCM  Vol.9 No.8 , August 2018
Study of Angiotensin Converting Enzyme Gene Polymorphism in Egyptian Type 2 Diabetes Mellitus with Diabetic Kidney Disease
Abstract: Objective: Diabetic kidney disease DKD (Diabetic nephropathy DN) is considered one of the chronic micro vascular complications of diabetes mellitus and considered the commonest cause leading to chronic renal failure and chronic renal dialysis. Genetic susceptibility has been implicated in DKD. The angiotensin converting enzyme (ACE) is one of the key roles in the renin angiotensin system cascade by converting angiotensin I to angiotensin II which plays a key role in regulation of blood pressure as well as electrolytes and fluid balance. This study addressed the association of (ACE) gene polymorphisms with DN in Egyptian (T2DM) patients. Methods: Our research comprised of 75 cases of T2DM with diabetic kidney disease, 100 cases of T2DM without DKD and 94 healthy volunteers. Different genotypes of ACE gene were determined by SSP-PCR analysis. Results: Gene polymorphism of ACE (DD, ID, II) in diabetic patient with DKD is 44%, 52%, 4% respectively and for T2DM individuals without DKD is 23%, 72%, 5% respectively. (DD) had significant higher frequencies in T2DM patients with DKD compared to those without DKD (p < 0.005) and (ID) had significant higher frequencies in T2DM without DKD (p < 0.0001). These results indicated that there is an association between ACE gene polymorphisms and susceptibility of diabetic patients to be affected by diabetic kidney disease. Conclusion: From our results, we can conclude that genotype of ACE in Egypt DD is the genotype of cases diabetic kidney disease. So the presence of D allele has a significant relation with diabetic kidney disease. Our data confirm the role of ACE in its relationship with diabetic kidney disease in Egyptian type 2 diabetic patients.
Cite this paper: El-baz, R. , Wafa, A. , Marrawan, E. , El-Tawab, A. and Aly, Z. (2018) Study of Angiotensin Converting Enzyme Gene Polymorphism in Egyptian Type 2 Diabetes Mellitus with Diabetic Kidney Disease. International Journal of Clinical Medicine, 9, 629-643. doi: 10.4236/ijcm.2018.98053.
References

[1]   Tang, S.C., Chan, G.C. and Lai, K.N. (2016) Recent Advances in Managing and Understanding Diabetic Nephropathy. F1000 Research, 5, 1000-1044.
https://doi.org/10.12688/f1000research.7693.1

[2]   Stephens, J.W. (2005) The D Allele of the ACE/ID Common Gene Variant Is Associated with T2D Mellitus in Caucasian Subjects. Molecular Genetics and Metabolism, 84, 83-88.
https://doi.org/10.1016/j.ymgme.2004.09.002

[3]   Chiarelli, F., Gaspari, S. and Marcovecchio, M.L. (2009) Role of Growth Factors in Diabetic Kidney Disease. Hormone and Metabolic Research, 41, 585-593.
https://doi.org/10.1055/s-0029-1220752

[4]   Sun, J., Xu, Y., Zhu, Y. and Lu, H. (2004) Genetic Polymorphism of Methylenetetrahydrofolate Reductase as a Risk Factor for Diabetic Nephropathy in Chinese Type 2 Diabetic Patients. Diabetes Research and Clinical Practice, 64, 185-190.
https://doi.org/10.1016/j.diabres.2003.10.022

[5]   Freedman, B.I., Bowden, D.W., Rich, S.S., Valis, C.J., Sale, M.M., Hicks, P.J., et al. (2005) A Genome Scan for All-Cause End-Stage Renal Disease in African Americans. Nephrology Dialysis Transplantation, 20, 712-718.
https://doi.org/10.1093/ndt/gfh704

[6]   Parvanova, A., Iliev, I., Dimitrov, B.D., Arnoldi, F., Zaletel, J., Remuzzi, G. and Ruggenenti, P. (2002) Hyperhomocysteinemia and Increased Risk of Retinopathy: A Cross-Sectional, Case-Control Study in Patients with Type 2 Diabetes. Diabetes Care, 25, 2361.
https://doi.org/10.2337/diacare.25.12.2361

[7]   Mtiraoui, N., Ezzidi, I., Chaieb, M., Marmouche, H., Aouni, Z., Chaieb, A., Mahjoub, T., Vaxillaire, M. and Almawi, W.Y. (2007) MTHFR C677T and A1298C Gene Polymorphisms and Hyperhomocysteinemia as Risk Factors of Diabetic Nephropathy in Type 2 Diabetes Patients. Diabetes Research and Clinical Practice, 75, 99-106.
https://doi.org/10.1016/j.diabres.2006.05.018

[8]   Wang, F., Maggie, Y., Wing, N.S., et al. (2005) Prognostic Effect of Insertion/Deletion Polymorphism of the ACE Gene on Renal and Cardiovascular Clinical Outcomes in Chinese Patients with Type-2 Diabetes. Diabetes Care, 54, 301-306.

[9]   Chang, H.R., Cheng, C.H., Shu, K.H., Chen, C.H., Lien, J.D. and Wu, M.Y. (2003) Study of the Polymorphism of Angiotensinogen, Angiotensin Converting Enzyme and Angiotensin Receptor in Type II Diabetes with End-Stage Renal Disease in Taiwan. Journal of the Chinese Medical Association, 66, 51-56.

[10]   Klemm, T., Mittrach-Schorins, S., Neumann, S., Gerike, T., krankenberg, H., Schuler, G., et al. (2003) No Association between the Angiotensin-Converting-Enzyme Gene Insertion/Deletion Polymorphism and the Occurrence of Macroangiopaty in Patients with Diabetes Mellitus Type 2. Hormone and Metabolic Research, 35, 43-47.
https://doi.org/10.1055/s-2003-38390

[11]   Zhu, X., Chang, Y., Yan, D., Weder, A., Cooper, R., Luke, A., et al. (2003) Associations between Hypertension and Genes in the Rennin Angiotensin System. Hypertension, 41, 1027-1037.
https://doi.org/10.1161/01.HYP.0000068681.69874.CB

[12]   Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A Simple Salting out Procedure for Extracting DNA from Human Nucleated Cells. Nucleic Acids Research, 16, 12-15.
https://doi.org/10.1093/nar/16.3.1215

[13]   Tanaka, C., Kamide, K., Takiachi, S., Miwa, Y., Yoshiim, M., Kawano, Y., et al. (2003) An Alternative Fast and Convenient Genotyping Method for the Screening of Angiotensin Converting Enzyme Gene Polymorphism. Hypertension Research, 26, 301-306.
https://doi.org/10.1291/hypres.26.301

[14]   Tanaka, N. and Babazono, T. (2005) Assessing Genetic Susceptibility to Diabetic Nephropathy. Nephrology, 10, S17-S21.
https://doi.org/10.1111/j.1440-1797.2005.00451.x

[15]   Erdös, E.G. and Skidgel, R.A. (1987) The Angiotensin I Converting Enzyme. Laboratory Investigation, 56, 345-348.

[16]   Födinger, M., Hörl, W.H. and Sunder-Plassmann, G. (2000) Molecular Biology of 5,10-Methylenetetrahydrofolate Reductase. Journal of Nephrology, 13, 20-33.

[17]   Palomo-Piñón, S., Gutiérrez-Rodríguez, M.E., Díaz-Flores, M., Sánchez-Barrera, R., Valladares-Salgado, A., Utrera-Barillas, D., Durán-Reyes, G., Galván-Duarte, R.E., Trinidad-Ramos, P. and Cruz, M. (2009) DD Genotype of Angiotensin-Converting Enzyme in Type 2 Diabetes Mellitus with Renal Disease in Mexican Mestizos. Nephrology (Carlton), 14, 235-239.
https://doi.org/10.1111/j.1440-1797.2008.01034.x

[18]   Movva, S., Alluri, R.V., Komandur, S., Vattam, K., Eppa, K., Mukkavali, K.K., Mubigonda, S., Saharia, S., Shastry, J.C. and Hasan, Q. (2007) Relationship of Angiotensin-Converting Enzyme Gene Polymorphism with Nephropathy Associated with Type 2 Diabetes Mellitus in Asian Indians. Journal of Diabetes and Its Complications, 21, 237-241.
https://doi.org/10.1016/j.jdiacomp.2006.07.001

[19]   Ha, S.K., Park, H.C., Park, H.S., Kang, B.S., Lee, T.H., Hwang, H.J., Kim, S.J., Kim, D.H., Kang, S.W., Choi, K.H., Lee, H.Y. and Han, D.S. (2003) ACE Gene Polymorphism and Progression of Diabetic Nephropathy in Korean Type 2 Diabetic Patients: Effect of ACE Gene DD on the Progression of Diabetic Nephropathy. American Journal of Kidney Diseases, 41, 943-949.
https://doi.org/10.1016/S0272-6386(03)00191-4

[20]   Kuramoto, N., Iizuka, T., Ito, H., Yagui, K., Omura, M., Nozaki, O., Nishikawa, T., Tsuchida, H., Makino, H., Saito, Y. and Kanatsuka, A. (1999) Effect of ACE Gene on Diabetic Nephropathy in NIDDM Patients with Insulin Resistance. American Journal of Kidney Diseases, 33, 276-281.
https://doi.org/10.1016/S0272-6386(99)70300-8

[21]   Mizuiri, S., Hemmi, H., Inoue, A., Yoshikawa, H., Tanegashima, M., Fushimi, T., Ishigami, M., Amagasaki, Y., Ohara, T., Shimatake, H., et al. (1995) Angiotensin-Converting Enzyme Polymorphism and Development of Diabetic Nephropathy in Non-Insulin-Dependent Diabetes Mellitus. Nephron, 70, 455-459.
https://doi.org/10.1159/000188645

[22]   Arfa, I., Abid, A., Nouira, S., Elloumi-Zghal, H., Malouche, D., Mannai, I., Zorgati, M.M., Ben, Alaya, N., Rebai, A., Zouari, B., Ben, Ammar, S., Ben, Rayana, M.C., Hmida, S., Blousa-Chabchoub, S. and Abdelhak, S. (2008) Lack of Association between the Angiotensin-Converting Enzyme Gene (I/D) Polymorphism and Diabetic Nephropathy in Tunisian Type 2 Diabetic Patients. Journal of the Renin-Angiotensin-Aldosterone System, 9, 32-36.
https://doi.org/10.3317/jraas.2008.002

[23]   Liao, L., Lei, M.X. and Chen, H.L. (2003) Angiotensin Converting Enzyme Gene Polymorphism and Type 2 Diabetic Nephropathy. Bulletin of Hunan Medical University, 28, 553-556.

[24]   Araz, M., Aynacioglu, S., Okan, V., Akdemir, I., et al. (2002) Angiotensin-Converting Enzyme Gene Polymorphism and Coronary Heart Disease in Turkish Type 2 Diabetic Patients. Acta Cardiologica, 57, 265-269.
https://doi.org/10.2143/AC.57.4.2005424

[25]   Grzeszczak, W., Zychma, M.J., Lacka, B. and Zukowska-Szczechowska, E. (1998) Angiotensin I-Converting Enzyme Gene Polymorphisms: Relationship to Nephropathy in Patients with Non-Insulin Dependent Diabetes Mellitus. Journal of the American Society of Nephrology, 9, 1664-1669.

[26]   Schmidt, S. and Ritz, E. (1997) Angiotensin I Converting Enzyme Gene Polymorphism and Diabetic Nephropathy in Type II Diabetes. Nephrology Dialysis Transplantation, 12, 37-41.

 
 
Top